Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40
Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121
HealthEquity Adds Further to Expand Presence in HSA Market
The Utah-based managed care company HealthEquity, Inc. (NASDAQ: HQY) announced earlier this month the acquisition of Further, a leading provider of health savings accounts (HSA) and consumer-directed benefit administration services. HealthEquity is paying $500 million for Further, approximately 8.33x the company’s annualized revenue run-rate and 41.7x estimated EBITDA. Further is a leading provider of HSA and consumer-directed benefit administration services, and the nation’s ninth-largest HSA custodian overall. Further is also a technology leader in employer-funded Voluntary Employees’ Beneficiary Association (VEBA) trust administration. VEBAs are triple-tax advantaged health accounts... Read More »
Health Care M&A Deals, April 9, 2021
The Health Care M&A deals chart is a selection of transactions announced during the prior week(s). The M&A transactions presented here are from our HealthCareMandA.com Deal Database, which is updated daily to provide our subscribers with the most up-to-date information and trends in the healthcare industry. The largest deal of the week is Better Therapeutics, Inc.’s reverse merger with Mountain Crest Acquisition Corp II, a publicly traded special purpose acquisition company. The deal is valued at $187 million. Better Therapeutics is a prescription digital therapeutics company delivering cognitive behavioral therapy to address the root causes of cardiometabolic... Read More »
Better Therapeutics Goes Public
A San Francisco-based cognitive therapy company is going public through a SPAC. Better Therapeutics, Inc. is merging with Mountain Crest Acquisition Corp II (NASDAQ: MCAD), a publicly traded special purpose acquisition corporation. The deal is valued at $187 million, and existing shareholders will roll over 100% of their equity into the equity of the combined company. Better Therapeutics is a prescription digital therapeutics company delivering cognitive behavioral therapy to address the root causes of cardiometabolic diseases. The company’s platform blends clinical, behavioral, and psychological inputs into a series of therapy lessons and skill-building modules designed to isolate... Read More »
Microsoft Pushes Deeper Into Health With Nuance Buy
The technology and software giant Microsoft Corp. (NASDAQ: MSFT) is making another big push into the healthcare market. The company is buying Nuance Communications, Inc. for $19.7 billion ($56.00 per share) in cash, the largest transaction in the healthcare market of the year so far. The price is a 23% premium to the closing price of Nuance on Friday, April 9, and is valued at approximately 14.25x and 89.47x Nuance’s Q4:20 annualized revenue and EBITDA, respectively. Nuance provides conversational AI and cloud-based ambient clinical intelligence for healthcare providers. Nuance’s products include the Dragon Ambient eXperience, Dragon Medical One and PowerScribe One for radiology... Read More »
What’s Next for eHealth?
The eHealth market is as active as ever. Digital health companies were in hot demand throughout 2020, with 246 deals on the books for last year, an annual record for the sector. In the first quarter of 2021, we already have 102 deals, according to search results in our Healthcare Deals Database. In 2020, it was all about virtual care and telehealth, exemplified by eHealth deals such as Teladoc Health, Inc.’s (NYSE: TDOC) $18.5 billion acquisition of Livongo Health, Inc. or the $1.35 billion reverse merger of UpHealth and Cloudbreak Health with Oaktree Acquisition Corp., a special purpose acquisition company. Much of the demand in eHealth was due to the Covid-19 pandemic, but other... Read More »
Healthcare M&A Results Q1: One for the Record Books
Rebound might be an understatement. After the healthcare M&A market slowed down for most of 2020 due to the pandemic, deal activity has roared back in the first quarter of 2021, with a staggering 596 deals on the books, a 17% increase compared to the 509 deals announced in Q4:20, according to results in Healthcare Deals Database. And with quarterly earnings on the way, the number of deals will easily break 600. In terms of disclosed spending, dollar volume sits at a healthy $89 billion, a 27% drop compared with Q4:20, but the last quarter of the year is always full of mega-mergers, so don’t just take that number at face value. It’s a strange endeavor comparing healthcare M&A... Read More »
Health Care M&A Deals, April 2 , 2021
The Health Care M&A deals chart is a selection of transactions announced during the prior week(s). The M&A transactions presented here are from our HealthCareMandA.com Deal Database, which is updated daily to provide our subscribers with the most up-to-date information and trends in the healthcare industry. The largest deal of the week is Procaps Group’s reverse merger with with Union Acquisition Corp. II (NASDAQ: LATN) valued at $1.128 billion. Founded in 1977 and based in Colombia, Procaps is a leading integrated international healthcare and pharmaceutical company with a successful history of growth and diversification. It is the largest pharmaceutical integral CDMO in... Read More »
SOC Telemed Acquires Access Physicians
The national telehealth provider SOC Telemed has announced a new deal for Access Physicians valued at $194 million upfront with additional potential consideration based on performance. Access Physicians is an experienced multi-specialty acute inpatient telemedicine provider focused on cardiac care, inpatient hospital care, tele-neurology, maternal-fetal expertise, tele-pulmonary and infectious disease management. SOC Telemed (f.k.a Specialists On Call, Inc.) just went public over the summer through a reverse merger with Healthcare Merger Corp., a special purpose acquisition company. The deal valued SOC Telemed at $720 million, and institutional investors including BlackRock Inc., Baron... Read More »
Procaps Group Merges with Union Acquisition
If you were looking for another SPAC deal this week, say no more. Procaps Group announced a reverse merger with Union Acquisition Corp. II (NASDAQ: LATN). Founded in 1977, Procaps is a leading integrated international healthcare and pharmaceutical company with a successful history of growth and diversification. Procaps is the largest pharmaceutical integral CDMO in Latin America, and its proprietary portfolio of branded Rx and OTC products and services is sold, distributed, or provided to over 50 markets. It has six state-of-the-art manufacturing facilities in Latin America, including the first FDA-approved pharmaceutical plant in South America for selling Rx products into the United... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
